Finance

Lists
CLN:WSE
Celon Pharma SA
PLN 18.94
+0.53%
(+0.10) 1D
Oct 6, 1:18:41 PM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CLN...
Open
PLN 18.84
High
PLN 19.08
Low
PLN 18.66
Mkt. cap
1.02B
Avg. vol.
17.16K
Volume
8.05K
P/E ratio
9.23
52-wk high
PLN 23.50
52-wk low
PLN 18.00
EPS
PLN 2.05
Shares outstanding
53.91M
No. of employees
560
Open
PLN 18.84
High
PLN 19.08
Low
PLN 18.66
Mkt. cap
1.02B
Avg. vol.
17.16K
Volume
8.05K
P/E ratio
9.23
52-wk high
PLN 23.50
52-wk low
PLN 18.00
EPS
PLN 2.05
Shares outstanding
53.91M
No. of employees
560
News stories
From web sources and news partners
About Celon Pharma SA
CEO-
Employees560
Founded2002
Headquarters-
SectorPharmaceutical industry
Websitecelonpharma.com
Last report
Sep 16, 2026
Fiscal period
Q2 2026
EPS / Est. (PLN)
- / -
Revenue / Est. (PLN)
55.57M / 60.50M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
71.13M
66.67M
65.26M
55.57M
Cost of goods sold
16.83M
11.54M
16.70M
14.92M
Cost of revenue
16.83M
11.54M
16.70M
14.92M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33.02M
35.44M
36.08M
38.62M
Operating expense
46.24M
52.60M
54.54M
50.11M
Total operating expenses
63.07M
64.14M
71.23M
65.04M
Operating income
8.06M
2.53M
-5.98M
-9.46M
Other non operating income
-30.00K
-250.00K
169.05M
3.48M
EBT including unusual items
-2.77M
-6.57M
160.34M
-7.38M
EBT excluding unusual items
-2.77M
-6.57M
160.34M
-7.38M
Income tax expense
-6.43M
18.33M
1.70M
23.21M
Effective tax rate
232.29%
-279.14%
1.06%
-314.48%
Other operating expenses
2.20M
6.37M
7.33M
1.36M
Net income
3.66M
-24.90M
158.64M
-30.59M
Net profit margin
5.15%
-37.35%
243.09%
-55.05%
Earnings per share
-
-
-
-
Interest and investment income
-
149.00K
151.00K
151.00K
Interest expense
-
-341.00K
-915.00K
-1.55M
Net interest expenses
-
-192.00K
-764.00K
-1.40M
Depreciation and amortization charges
11.01M
10.78M
11.13M
10.13M
EBITDA
16.34M
11.40M
3.44M
-748.00K
Gain or loss from assets sale
-170.00K
-2.91M
-569.00K
716.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps